Orudis Capsule
Product Images NDC 28595-031

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Orudis (NDC 28595-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allegis Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (63853ed1 F011 4e5a 97b9 A737394abf42)

FDA Label Image

Label-1 (Label 1)

This is a description of Orudis (ketoprofen) capsules, a prescription medication containing 75mg of Ketoprofen, USP. It is recommended to consult the Medication Guide provided with the product and store it at 20° to 25°C (68 to 77°F). Dispensing should be in a light-resistant container with a child-resistant closure to ensure safety. The medication is distributed by Allegis Pharmaceuticals, Inc. in Canton, MS.*

FDA Label Image

Chart (Chart)

This text provides the comparison of pharmacokinetic parameters for Orudis, a medication taken in the 4 x 50 mg dosage. It lists various parameters such as the extent of oral absorption (bioavailability), peak plasma levels under fasted and fed conditions, time to peak concentration, area under the plasma concentration-time curve, oral-dose clearance, and half-life. The values presented are expressed as mean ± standard deviation to give a clear overview of the pharmacokinetics of Orudis.*

FDA Label Image

Image1 (Cee18009 1795 4bf9 9216 28b34d5dda16)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.